Pfizer launches first clinical trial of a PILL to treat COVID-19 that prevents the virus from making copies of itself inside human cells

Pfizer Inc has launched early-stage human trials of an experimental oral drug that could be prescribed to patients at the first sign of infection with COVID-19. Read More